Honculada, Queen Chell M.

HRN: 23-56-18  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/16/2023
CEFUROXIME 1.5GM (VIAL)
09/16/2023
09/17/2023
IV
1.5gms
Prior To OR
For Repeat CS
Waiting Final Action 
09/16/2023
CEFUROXIME 1.5GM (VIAL)
09/16/2023
09/18/2023
IV
1.5gms
Q8hours
S/P Repeat CS With BTL
Checking Final Appropriateness 
09/17/2023
CEFUROXIME 500MG (TAB)
09/17/2023
09/24/2023
PO
500
Bid
S/p LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: